Literature DB >> 19168577

Differential regulation of sphingosine kinases 1 and 2 in lung injury.

Raj Wadgaonkar1, Vipul Patel, Natalia Grinkina, Carol Romano, Jing Liu, Yutong Zhao, Saad Sammani, Joe G N Garcia, Viswanathan Natarajan.   

Abstract

Two mammalian sphingosine kinase (SphK) isoforms, SphK1 and SphK2, possess identical kinase domains but have distinct kinetic properties and subcellular localizations, suggesting each has one or more specific roles in sphingosine-1-phosphate (S1P) generation. Although both kinases use sphingosine as a substrate to generate S1P, the mechanisms controlling SphK activation and subsequent S1P generation during lung injury are not fully understood. In this study, we established a murine lung injury model to investigate LPS-induced lung injury in SphK1 knockout (SphK1(-/-)) and wild-type (WT) mice. We found that SphK1(-/-) mice were much more susceptible to LPS-induced lung injury compared with their WT counterparts, quantified by multiple parameters including cytokine induction. Intriguingly, overexpression of WT SphK1 delivered by adenoviral vector to the lungs protected SphK1(-/-) mice from lung injury and attenuated the severity of the response to LPS. However, adenoviral overexpression of a SphK1 kinase-dead mutant (SphKKD) in SphK1(-/-) mouse lungs further exacerbated the response to LPS as well as the extent of lung injury. WT SphK2 adenoviral overexpression also failed to provide protection and, in fact, augmented the degree of LPS-induced lung injury. This suggested that, in vascular injury, S1P generated by SphK2 activation plays a distinctly separate role compared with SphK1-dependent S1P generation and survival signaling. Microarray and real-time RT-PCR analysis of SphK1 and SphK2 expression levels during lung injury revealed that, in WT mice, LPS treatment caused significantly enhanced SphK1 expression ( approximately 5x) levels within 6 h, which declined back to baseline levels by 24 h posttreatment. In contrast, expression of SphK2 was gradually induced following LPS treatment and was elevated within 24 h. Collectively, our results for the first time demonstrate distinct functional roles of the two SphK isoforms in the regulation of LPS-induced lung injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168577      PMCID: PMC2670763          DOI: 10.1152/ajplung.90357.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  41 in total

1.  Essential role for sphingosine kinases in neural and vascular development.

Authors:  Kiyomi Mizugishi; Tadashi Yamashita; Ana Olivera; Georgina F Miller; Sarah Spiegel; Richard L Proia
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

2.  Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice.

Authors:  Barbara Zemann; Nicole Urtz; Roland Reuschel; Diana Mechtcheriakova; Frédéric Bornancin; Rudolf Badegruber; Thomas Baumruker; Andreas Billich
Journal:  Immunol Lett       Date:  2007-01-30       Impact factor: 3.685

3.  Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism.

Authors:  Zhu-Qiu Jin; Joel S Karliner
Journal:  Cardiovasc Res       Date:  2006-06-12       Impact factor: 10.787

4.  Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts.

Authors:  Shizhong Bu; Masayoshi Yamanaka; Huiping Pei; Alicja Bielawska; Jacek Bielawski; Yusuf A Hannun; Lina Obeid; Maria Trojanowska
Journal:  FASEB J       Date:  2005-11-08       Impact factor: 5.191

5.  Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1.

Authors:  Yutong Zhao; Satish K Kalari; Peter V Usatyuk; Irina Gorshkova; Donghong He; Tonya Watkins; David N Brindley; Chaode Sun; Robert Bittman; Joe G N Garcia; Evgeni V Berdyshev; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2007-03-22       Impact factor: 5.157

6.  Sphingosine 1-phosphate protects rat liver sinusoidal endothelial cells from ethanol-induced apoptosis: Role of intracellular calcium and nitric oxide.

Authors:  Dong-Mei Zheng; Tsuneo Kitamura; Kenichi Ikejima; Nobuyuki Enomoto; Shunhei Yamashina; Satoko Suzuki; Yoshiyuki Takei; Nobuhiro Sato
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

7.  Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells.

Authors:  P Xia; L Wang; J R Gamble; M A Vadas
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

8.  An oncogenic role of sphingosine kinase.

Authors:  P Xia; J R Gamble; L Wang; S M Pitson; P A Moretti; B W Wattenberg; R J D'Andrea; M A Vadas
Journal:  Curr Biol       Date:  2000-11-30       Impact factor: 10.834

Review 9.  Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.

Authors:  Volker Brinkmann
Journal:  Pharmacol Ther       Date:  2007-05-22       Impact factor: 12.310

10.  Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1.

Authors:  Xiaochun Li; Milena Stankovic; Claudine S Bonder; Christopher N Hahn; Michelle Parsons; Stuart M Pitson; Pu Xia; Richard L Proia; Mathew A Vadas; Jennifer R Gamble
Journal:  Blood       Date:  2008-01-16       Impact factor: 22.113

View more
  44 in total

Review 1.  Update on acute lung injury and critical care medicine 2009.

Authors:  Michael A Matthay; Steven Idell
Journal:  Am J Respir Crit Care Med       Date:  2010-05-15       Impact factor: 21.405

2.  Transient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability.

Authors:  Mohammad Tauseef; Mohammad Farazuddin; Sukriti Sukriti; Charu Rajput; James Otto Meyer; Suresh Kumar Ramasamy; Dolly Mehta
Journal:  FASEB J       Date:  2015-08-27       Impact factor: 5.191

Review 3.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

4.  Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.

Authors:  Barry S Shea; Sarah F Brooks; Benjamin A Fontaine; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

5.  A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury.

Authors:  Anke Di; Takeshi Kawamura; Xiao-Pei Gao; Haiyang Tang; Evgeny Berdyshev; Stephen M Vogel; You-Yang Zhao; Tiffany Sharma; Kurt Bachmaier; Jingsong Xu; Asrar B Malik
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

6.  Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways.

Authors:  Patrick Quint; Ming Ruan; Larry Pederson; Moustapha Kassem; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

Review 7.  Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.

Authors:  Barry S Shea; Andrew M Tager
Journal:  Proc Am Thorac Soc       Date:  2012-07

Review 8.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

9.  Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages.

Authors:  Hridayesh Prakash; Anja Lüth; Natalia Grinkina; Daniela Holzer; Raj Wadgaonkar; Alexis Perez Gonzalez; Elsa Anes; Burkhard Kleuser
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

Review 10.  Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.

Authors:  Viswanathan Natarajan; Steven M Dudek; Jeffrey R Jacobson; Liliana Moreno-Vinasco; Long Shuang Huang; Taimur Abassi; Biji Mathew; Yutong Zhao; Lichun Wang; Robert Bittman; Ralph Weichselbaum; Evgeny Berdyshev; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.